The AnteoTech (ASX:ADO) share price closed 43% higher today

The AnteoTech share price boomed over 40% higher today. Let's check out the company's latest announcement to see what's up.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Anteotech Ltd (ASX: ADO) share price gained a whopping 43.18% today, closing the day trading at 32 cents.

AnteoTech is a surface chemistry company with intellectual property in its core technology product groups. These include AnteoCoat, AnteoBind and AnteoRelease. The company's customers operate in the life sciences, diagnostics, energy and medical devices markets.

With no recent company announcements, let's take a look at what could be driving the AnteoTech share price.

AnteoTech share price zooms after Ellume secures US contract

Earlier this month, AnteoTech announced that its client, Ellume, had signed a deal with the US Defence Department for emergency use authorisation of its COVID-19 at-home test.

Ellume integrates AnteoBind technology in its proprietary quantum dot diagnostics platform.

The Ellume COVID-19 home test, incorporating AnteoBind, is the first non-prescription over-the-counter self-test authorised by the US Food and Drug Administration (FDA) for emergency use.

AnteoBind is a key element of AnteoTech's own COVID-19 Antigen Rapid Test currently in development and several other assays marketed globally.

AnteoTech advised that it has worked closely with Ellume over recent months to ensure it could supply the required volumes of AnteoBind.

The company expects that Ellume's requirement for AnteoBind will increase modestly over coming months as supply to the US markets takes off.

Words from the CEO

Commenting on the Ellume agreement, AnteoTech CEO Derek Thomson said:

We are delighted to be involved with Ellume's success and we congratulate the company on their announcement.

Ellume was the original seed customer in AnteoTech's strategy to demonstrate the value that AnteoBind can bring to assay development and it is pleasing to see that strategy now delivering market recogition.

I commend the work of AnteoTech's Life Science team under the leadership of Charlie Huang for their continued work to make AnteoBind a key element in the development of diagnostic products in global markets.

The AnteoTech share price has exploded more than 648% higher over the previous 12-month period.

Motley Fool contributor Gretchen Kennedy has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

a woman with lots of shopping bags looks upwards towards the sky as if she is pondering something.
Opinions

The pros and cons of buying Zip shares in 2026

There are positive and negative aspects about Zip shares right now…

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: CBA, REA Group, and Xero shares

Morgans has given its verdict on these popular stocks. Let's see if it is bullish on them.

Read more »

A man in a suit looks serious while discussing business dealings with a couple as they sit around a computer at a desk in a bank home lending scenario.
Share Market News

Here's what Westpac says the RBA will do with interest rates in 2026

Stick or twist? Let's see what the RBA could do with rates this year.

Read more »

A woman stretches her arms into the sky as she rises above the crowd.
Best Shares

Fastest rising ASX 200 share of each market sector in 2025

These shares outperformed their sector peers last year.

Read more »

A couple stares at the tv in shock, with the man holding the remote up ready to press a button.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Aristocrat, James Hardie, and TechnologyOne shares

Morgans has given its verdict on these popular shares. Is it bullish, bearish, or something in between?

Read more »

Group of entrepreneurs feeling frustrated during a meeting in the office. Focus is on man with headache.
Share Fallers

5 worst ASX All Ords shares of 2025, and why brokers rate 4 of them a buy

The ASX All Ords rose by 7.11% in 2025 but as always, there were losers in the pack.

Read more »

A female soldier flies a drone using hand-held controls.
Best Shares

These 5 ASX All Ords shares were the fastest risers of 2025

The ASX All Ords rose by 7.11% and delivered total returns, including dividends, of 10.56% in 2025.

Read more »